Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) ...Middle East

Initiating Phase 1b randomized clinical trial with initial results expected in late 2021 Potential for novel, preventive AT-100 to reduce incidence and severity of serious respiratory disease BPD, improving outcomes and survival in very preterm infants CINCINNATI, March 26, 2021...

Hence then, the article about airway therapeutics announces fda acceptance of ind for at 100 in preterm infants at risk for bronchopulmonary dysplasia bpd was published today ( Friday 26/03/2021 - 11:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) )

Also on site :

• En medio de la crisis, el Gobierno de Cuba anuncia reformas económicas aunque persisten los obstáculos
• LA28 ticket registration nears deadline as first Olympic qualifiers emerge
• What do you need to vote in Illinois? What you can take into the ballot box with you